IL6 and COVID-19: For COVID-19 patients who exhibit cytokine storms or secondary hemophagocytic lymphohistiocytosis (sHLH) accompanied by significantly increased levels of IL-6, ferritin, and D-dimer, these may be potential therapy (23).